biote Statistics
Total Valuation
biote has a market cap or net worth of $53.22 million. The enterprise value is $170.69 million.
| Market Cap | 53.22M |
| Enterprise Value | 170.69M |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 33.90 million shares outstanding. The number of shares has decreased by -7.45% in one year.
| Current Share Class | 28.68M |
| Shares Outstanding | 33.90M |
| Shares Change (YoY) | -7.45% |
| Shares Change (QoQ) | -20.47% |
| Owned by Insiders (%) | 16.99% |
| Owned by Institutions (%) | 39.95% |
| Float | 17.17M |
Valuation Ratios
The trailing PE ratio is 8.66 and the forward PE ratio is 52.33.
| PE Ratio | 8.66 |
| Forward PE | 52.33 |
| PS Ratio | 0.29 |
| Forward PS | 0.30 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.68 |
| P/OCF Ratio | 2.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.70, with an EV/FCF ratio of 8.59.
| EV / Earnings | 29.15 |
| EV / Sales | 0.93 |
| EV / EBITDA | 6.70 |
| EV / EBIT | 7.54 |
| EV / FCF | 8.59 |
Financial Position
The company has a current ratio of 1.43
| Current Ratio | 1.43 |
| Quick Ratio | 0.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.88 |
| Debt / FCF | 6.47 |
| Interest Coverage | 2.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 13.70% |
| Return on Invested Capital (ROIC) | 23.60% |
| Return on Capital Employed (ROCE) | 31.62% |
| Weighted Average Cost of Capital (WACC) | 7.44% |
| Revenue Per Employee | $823,009 |
| Profits Per Employee | $26,260 |
| Employee Count | 223 |
| Asset Turnover | 1.78 |
| Inventory Turnover | 3.22 |
Taxes
In the past 12 months, biote has paid $3.18 million in taxes.
| Income Tax | 3.18M |
| Effective Tax Rate | 30.98% |
Stock Price Statistics
The stock price has decreased by -53.27% in the last 52 weeks. The beta is 1.65, so biote's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | -53.27% |
| 50-Day Moving Average | 1.97 |
| 200-Day Moving Average | 2.12 |
| Relative Strength Index (RSI) | 42.83 |
| Average Volume (20 Days) | 322,518 |
Short Selling Information
The latest short interest is 658,978, so 1.94% of the outstanding shares have been sold short.
| Short Interest | 658,978 |
| Short Previous Month | 538,647 |
| Short % of Shares Out | 1.94% |
| Short % of Float | 3.84% |
| Short Ratio (days to cover) | 3.06 |
Income Statement
In the last 12 months, biote had revenue of $183.53 million and earned $5.86 million in profits. Earnings per share was $0.18.
| Revenue | 183.53M |
| Gross Profit | 127.46M |
| Operating Income | 22.64M |
| Pretax Income | 10.26M |
| Net Income | 5.86M |
| EBITDA | 25.48M |
| EBIT | 22.64M |
| Earnings Per Share (EPS) | $0.18 |
Balance Sheet
The company has $11.17 million in cash and $128.64 million in debt, with a net cash position of -$117.47 million or -$3.47 per share.
| Cash & Cash Equivalents | 11.17M |
| Total Debt | 128.64M |
| Net Cash | -117.47M |
| Net Cash Per Share | -$3.47 |
| Equity (Book Value) | -58.19M |
| Book Value Per Share | -2.38 |
| Working Capital | 12.94M |
Cash Flow
In the last 12 months, operating cash flow was $24.37 million and capital expenditures -$4.50 million, giving a free cash flow of $19.87 million.
| Operating Cash Flow | 24.37M |
| Capital Expenditures | -4.50M |
| Depreciation & Amortization | 2.85M |
| Net Borrowing | 89.31M |
| Free Cash Flow | 19.87M |
| FCF Per Share | $0.59 |
Margins
Gross margin is 69.45%, with operating and profit margins of 12.33% and 3.19%.
| Gross Margin | 69.45% |
| Operating Margin | 12.33% |
| Pretax Margin | 5.59% |
| Profit Margin | 3.19% |
| EBITDA Margin | 13.89% |
| EBIT Margin | 12.33% |
| FCF Margin | 10.83% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.45% |
| Shareholder Yield | n/a |
| Earnings Yield | 11.00% |
| FCF Yield | 37.34% |
Analyst Forecast
The average price target for biote is $2.61, which is 66.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.61 |
| Price Target Difference | 66.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 0.82% |
| EPS Growth Forecast (3Y) | -3.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 2.3 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.3 |
| Piotroski F-Score | 5 |